US stocks are landing at Stockopedia Find out more
Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value

Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2008 2009 2010 2011 2012 2013 2014E 2015E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p -21.0%

FINANCIAL BRIEF: For the fiscal year ended 31 December 2013, Medilink-Global UK Ltd revenues decreased 1% to L2.1M. Net loss decreased 4% to L676K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Administrative Expenses decrease of 3% to L1.5M (expense), Other income increase of 7% to L16K (income). more »

Health Trend

Bankruptcy Risk

  Earnings Manipulation Risk

Magic Formula Score  
E+
E+

Other Ratios
Leverage (ttm) Total Ex Intang
Gross Gearing %
Net Gearing %
Cash / Assets %

vs.
market
vs.
industry
Recent History
Latest interim period (ended 31st Dec '13) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2014
31st Dec 2015

Price Target: N/A Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (£) (£) (£) (£) (£)
Consensus Estimate
1m Change
3m Change
Broker Consensus Trend
Broker Recommendations for Medilink Global UK
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts:

Named Brokers and Analysts
Daniel Stewart Vadim Alexandre , Allenby Capital Tom McColm ,

Profile Summary

Medilink Global UK Ltd provides third party administrator services, through Electronic Health card Network that facilitates the administration of medical claims and healthcare data management for insurance companies and corporate clients. The Company offers its Third party administrator services to facilitate the administration of both the in-patient and out-patient healthcare schemes of corporate organizations and insurance companies. The Company’s Electronic Claims Clearance System is a customized application system for healthcare claims processing and healthcare data management. Its E-Health Management Platform uses Internet and mobile technology to deliver valuable content, guidance and advice about health and wellness. The Company operates in two segments: Third party administrator and Software licensing. The Company’s subsidiaries include Medilink-Global (Asia) Pte Ltd, MedilinkGlobal (Malaysia) Sdn Bhd and Medilink-Global TPA Pte Ltd.

Directors: Kok Fat Shia (CEO) 51, Norman Lott (NEC) 57, Shien Yee Chen (NED) 48,

No. of Employees: 41 No. of Shareholders: 0


Last Annual December 31st, 2013
Last Interim December 31st, 2013
Shares in Issue 120,909,108
ISIN JE00B3FFC377
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

Address Queensway House,Hilgrove StreetSt Helier Road, SAINT HELIER, JE1 1ES, Jersey
Web
Phone +
Contact ()
Auditors Crowe Clark Whitehill LLP

MEDI Share Price Performance MEDI Quote
2.88p
0.1  4.5%
Traded 9:22am · Minimum 15 min delayed · NMS: 20.0k

Latest MEDI News Announcements (delayed)

Upcoming MEDI Events
Friday 17th July, 2015 (estimate)
Medilink Global UK Ltd Annual Shareholders Meeting

Recent ↓
Thursday 17th July, 2014
Medilink Global UK Ltd Annual Shareholders Meeting
Thursday 7th October, 2010
Medilink-Global UK Ltd Secondary Public Offering Pricing
Thursday 7th October, 2010
Medilink-Global UK Ltd Secondary Public Offering Pricing


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2014.


Should you buy MEDI

Access MEDI Analytics Now!

FREE TRIAL or TAKE THE TOUR